Propanc Biopharma (PPCB) Non Operating Interest Expenses (2011 - 2025)
Propanc Biopharma (PPCB) reported Non Operating Interest Expenses of $430,539 for FY2026 (year ended Jun 30, 2026), down 23.6% from $563,757 in FY2025.
Powered by 
Analysis
Propanc Biopharma (PPCB) Non Operating Interest Expenses (2011 - 2025) Analysis & Trends
Dating back to FY2012, Propanc Biopharma's Non Operating Interest Expenses record includes 15 fiscal years.
- Non Operating Interest Expenses has a five-year compound annual growth rate of -0.9% (FY2021 to FY2026).
- The FY2026 figure ranks as the lowest annual Non Operating Interest Expenses since FY2014.
- According to Business Quant data, Non Operating Interest Expenses came in at $563,757 in FY2025 (-15.3%), $665,841 in FY2024 (+25.0%), $532,821 in FY2023 (-6.3%) and $568,798 in FY2022 (+26.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Propanc Biopharma | 550,617.42 | 550,617.42 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 58,955.00 |
| Sep 30, 2025 | 305,649.00 |
| Jun 30, 2025 | 254,542.00 |
| Mar 31, 2025 | 104,042.00 |
| Dec 31, 2024 | 118,943.00 |
| Sep 30, 2024 | 86,230.00 |
| Jun 30, 2024 | 90,004.00 |
| Mar 31, 2024 | 133,141.00 |
| Dec 31, 2023 | 264,462.00 |
| Sep 30, 2023 | 178,234.00 |
| Jun 30, 2023 | 114,242.00 |
| Mar 31, 2023 | 157,208.00 |
| Dec 31, 2022 | 98,619.00 |
| Sep 30, 2022 | 162,752.00 |
| Jun 30, 2022 | 113,665.00 |
| Mar 31, 2022 | 167,375.00 |
| Dec 31, 2021 | 177,905.00 |
| Sep 30, 2021 | 109,853.00 |
| Jun 30, 2021 | 29,440.00 |
| Mar 31, 2021 | 102,901.00 |
API Access
Propanc Biopharma Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();